Los Angeles Capital Management
OPRX icon

Los Angeles Capital Management’s OptimizeRx OPRX Stock Holding History

Los Angeles Capital Management’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,866
Closed -$99.6K – 2458
2026
Q1 		$99.6K Sell
15,866
-28,711
-64% -$267K ﹤0.01% 1336
2025
Q4 		$874K Sell
44,577
-3,913
-8% -$63.9K ﹤0.01% 682
2025
Q3 		$994K Buy
48,490
+22,667
+88% +$360K ﹤0.01% 707
2025
Q2 		$349K Buy
+25,823
New +$282K ﹤0.01% 996
2023
Q4 		– Sell
-29,782
Closed -$232K – 1211
2023
Q3 		$232K Buy
29,782
+5,530
+23% +$60.2K ﹤0.01% 1034
2023
Q2 		$347K Buy
24,252
+700
+3% +$9.97K ﹤0.01% 957
2023
Q1 		$345K Sell
23,552
-600
-2% -$10K ﹤0.01% 967
2022
Q4 		$406K Sell
24,152
-46,900
-66% -$811K ﹤0.01% 948
2022
Q3 		$1.05M Buy
71,052
+18,240
+35% +$361K 0.01% 679
2022
Q2 		$1.45M Buy
+52,812
New +$1.56M 0.01% 612

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Los Angeles Capital Management's OPRX Position: Q2 2026 in Review

Los Angeles Capital Management sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 15,866 shares — an estimated $99.6K sold.

Los Angeles Capital Management first reported a position in OPRX in Q2 2022 and held it in 10 quarters. The position peaked at $1.45M in Q2 2022. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Los Angeles Capital Management reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
  • Los Angeles Capital Management sold 15,866 OptimizeRx shares in Q2 2026, an estimated $99.6K.
  • Los Angeles Capital Management first reported a position in OptimizeRx in Q2 2022 and held it in 10 quarters.
  • Los Angeles Capital Management's OptimizeRx position peaked at $1.45M in Q2 2022.
  • 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.